T1	intervention 39 71	recombinant human interleukin-11
T2	condition 83 120	chemotherapy-induced thrombocytopenia
T4	control 850 857	placebo
T6	total-participants 958 971	Seventy-seven
T7	total-participants 1050 1061	Sixty-seven
T8	outcome 1337 1358	platelet transfusions
T9	iv-bin-abs 1360 1362	27
T10	intervention-participants 1366 1368	40
T11	iv-bin-percent 1370 1373	68%
T12	cv-bin-abs 1449 1451	15
T13	control-participants 1455 1457	37
T14	cv-bin-percent 1459 1462	41%
T15	outcome 1726 1740	adverse events
T5	outcome 1545 1591	total number of platelet transfusions required
T16	outcome 1637 1662	time to platelet recovery
T3	eligibility 631 664	Women with advanced breast cancer
